ClinicalTrials.gg
CompletedNCT07200843Updated Oct 1, 2025

Comparison of Lower Extremity Biomechanics and Postural Stability in Individuals With Pes Planus

An observational study in Pes Planus, sponsored by sevilay seda bas. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-01.

Sponsored by sevilay seda bas · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
41
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 57 studies in Flatfoot with a site in Turkey — 10 open to participants now, 12 under way, none of them phase 3. Flatfoot · Turkey.

Enrollment
13th of 21
41 · median 48
Started
2022
with 10 others
Observational
21 of 57
1 open now
Registered
46th of 57
by date

Among the 57 studies in Flatfoot with a site in Turkey, this one is the 13th largest by enrollment of the 21 observational ones that give a count, is one of 11 that started in 2022, is one of 21 observational ones, and was the 46th registered.

Flatfoot

173 studies on the registry are indexed under Flatfoot; 44 are open to participants now.

Browse Flatfoot studies →

Open to participants now

10 of the 57 studies in Flatfoot with a site in Turkey are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 24 Flatfoot studies recruiting now, 3 (13%) set no upper age limit and 20 (83%) stop at 75 or younger; 8 take children under 18; 6 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 57 studies in Flatfoot with a site in Turkey, or all of them as a file.
02

Study summary

The goal of this observational study is to examine the relationship between plantar flexor endurance and postural and tibial sway in adults (≥18 years) with pes planus (flatfoot). The main questions it aims to answer are:

Is there a correlation between plantar flexor endurance, postural sway and tibial sway during single-leg stance?

Participants will:

Perform a heel rise test to assess plantar flexor endurance

Stand on one leg while wearing a motion sensor to measure postural and tibial sway

Complete the tests under both eyes-open and eyes-closed conditions

03

Conditions studied

  • Pes Planus

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of adults aged 18 years and older with a navicular drop test result of at least 10 mm. Participants were recruited through convenience sampling from the university student population. Individuals with chronic diseases, hearing or vision impairments, orthopedic injuries or surgical history, or leg length discrepancy were excluded.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants aged 18 years and older
  • A navicular drop test result of at least 10 mm

Exclusion criteria

Exclusion Criteria:

  • Individuals with chronic diseases, hearing or vision impairments, orthopedic injuries or surgical history, and leg length discrepancy
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
41 participants (actual)
Patient registry
No

Groups and cohorts

  • Pes Planus Group

    Participants aged 18 years and older with a navicular drop test result of at least 10 mm were included. Individuals with chronic diseases, hearing or vision impairments, orthopedic injuries or surgical history, and leg length discrepancy were excluded.

    Other: Heel rise test and postural/tibial sway measurement

Interventions

  • OtherHeel rise test and postural/tibial sway measurement

    Participants undergo a heel rise test to assess plantar flexor muscle endurance. Postural and tibial sway are measured during single-leg stance using a wearable sensor under eyes-open and eyes-closed conditions. No therapeutic intervention is applied.

06

What researchers measure

Primary outcomes

  1. Plantar flexor endurance measured by heel rise test

    The number of repetitions participants can perform during the heel rise test, assessing the endurance of the plantar flexor muscles. Participants stood on one leg and raised their heels in time with a metronome set at 40 beats per minute. The test ended when the participant was fatigued or unable to continue, and the number of heel rises completed was recorded. The test was performed on both lower limbs.

    Time frame: Measured once at baseline during the study visit.

Secondary outcomes

  1. Postural sway during single-leg stance

    Postural sway was assessed using the Alda Balance Gear wearable sensor. Sensor was assessed for medio-lateral (ML) and antero-posterior (AP) sway. The sensor was placed at the L3-L5 vertebral level using a belt device. Participants performed a single-leg stance for up to 30 seconds under eyes-open (EO) and eyes-closed (EC) conditions. The test ended if balance was lost and the foot touched the ground. Postural sway was recorded only on the dominant limb.

    Time frame: Measured once at baseline during the study visit.

  2. Tibial sway during single-leg stance

    Tibial sway was assessed using the Alda Balance Gear wearable sensor. Sensor was assessed AP and ML sway. The sensor was placed one-third distal on the lower leg. Participants performed a single-leg stance for up to 30 seconds under eyes-open (EO) and eyes-closed (EC) conditions. The test ended if balance was lost and the foot touched the ground. Tibial sway was measured on both lower limbs.

    Time frame: Measured once at baseline during the study visit.

07

Study locations

1 site
  • Ankara Yıldırım Beyazıt University, Department of Physiotherapy and Rehabilitation
    Ankara, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2022 to primary completion in Oct 2022, 4 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2025
First posted
Oct 1, 2025
StartActual
Jun 29, 2022
Primary completionActual
Oct 31, 2022
CompletionActual
Oct 31, 2022
Last update
Oct 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07200843
Lead sponsor
sevilay seda bas
Responsible party
sevilay seda bas (Asst. Prof., Ankara Yildirim Beyazıt University) — Sponsor-investigator
First posted
Oct 1, 2025
Start date
Jun 29, 2022
Primary completion
Oct 31, 2022
Completion
Oct 31, 2022
Last update
Oct 1, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion